Milestone Pharmaceuticals Inc.
MIST· Nasdaq
Released Aug 12, 2026, before the open
10-Q filed Aug 12, 2026, 43 days after period end · 0001104659-26-094435
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $559.00K | $0.00 | — | — |
| Net Income | -$28.61M | -$12.97M | -$9.36M | -$16.04M |
| EPS Diluted |
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
| -$0.21 |
| -$0.20 |
| -$0.14 |
| -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.